High Free Cash Flow Stocks
MDT is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
NYSE:MDT • IE00BTN1Y115
The current stock price of MDT is 83.22 USD. Today MDT is up by 1.49%. In the past month the price decreased by -3.88%. In the past year, price decreased by -1.12%.
MDT currently appears in the following ChartMill screener lists.
ChartMill assigns a technical rating of 0 / 10 to MDT. When comparing the yearly performance of all stocks, MDT is a bad performer in the overall market: 80.18% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to MDT. MDT has an excellent profitability rating, but there are some minor concerns on its financial health.
On February 17, 2026 MDT reported an EPS of 1.36 and a revenue of 9.02B. The company beat EPS expectations (0.89% surprise) and beat revenue expectations (0.26% surprise).
37 analysts have analysed MDT and the average price target is 111.21 USD. This implies a price increase of 33.63% is expected in the next year compared to the current price of 83.22.
For the next year, analysts expect an EPS growth of 2.83% and a revenue growth 7.95% for MDT
Over the last trailing twelve months MDT reported a non-GAAP Earnings per Share(EPS) of 5.6. The EPS increased by 4.87% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13% | ||
| ROA | 5.04% | ||
| ROE | 9.42% | ||
| Debt/Equity | 0.57 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 14.59 | 161.117B | ||
| ISRG | INTUITIVE SURGICAL INC | 41.46 | 160.285B | ||
| SYK | STRYKER CORP | 21.78 | 125.349B | ||
| BSX | BOSTON SCIENTIFIC CORP | 18.6 | 88.457B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.06 | 45.956B | ||
| IDXX | IDEXX LABORATORIES INC | 39.06 | 45.191B | ||
| BDX | BECTON DICKINSON AND CO | 11.4 | 44.616B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.81 | 32.972B | ||
| RMD | RESMED INC | 18.08 | 32.227B | ||
| DXCM | DEXCOM INC | 24.93 | 24.092B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.97 | 17.942B | ||
| PODD | INSULET CORP | 29.86 | 13.321B | ||
| PEN | PENUMBRA INC | 65.18 | 12.858B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company is headquartered in Galway, Connacht and currently employs 95,000 full-time employees. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
IPO: 1977-11-21
MEDTRONIC PLC
Building Two Parkmore Business Park West
GALWAY CONNACHT D02 IE
CEO: Geoffrey S. Martha
Employees: 95000
Phone: 35314381700
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company is headquartered in Galway, Connacht and currently employs 95,000 full-time employees. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
The current stock price of MDT is 83.22 USD. The price increased by 1.49% in the last trading session.
MEDTRONIC PLC (MDT) has a dividend yield of 3.32%. The yearly dividend amount is currently 2.77.
MDT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
The next ex-dividend date for MEDTRONIC PLC (MDT) is March 27, 2026.
The Revenue of MEDTRONIC PLC (MDT) is expected to grow by 7.95% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
MEDTRONIC PLC (MDT) will report earnings on 2026-06-03, after the market close.